US hospital group Agreement

Surgical Innovations Group PLC 18 December 2006 Press Release 18 December 2006 Surgical Innovations Group plc ('Surgical' or 'the Group') Provider of Choice for major US hospital group Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative surgical devices, today announces that it has been approved by the North Shore Long Island Jewish Health System ('North Shore') as an accredited supplier of laparoscopic equipment. Following extensive trials across all disciplines of laparoscopic surgery within the North Shore hospital group, the Group's market-leading 'resposable' (a mixture of both reusable and disposable items) and versatile YelloPort abdominal access system will be supplied to operating theatres in pre-prepared equipment trays, tailored to each type of operation. North Shore is the USA's third-largest non-profit secular healthcare systems group, comprising 15 hospitals, with in excess of 6,000 beds. With a US$4 billion annual operating budget and more than 38,000 employees, North Shore services an area of 5.2 million people in New York State. North Shore treats more than 235,000 in-patients annually and offers a full spectrum of advanced minimally invasive procedures. There are 4.4 million laparoscopic surgical procedures carried out each year in the US (Source: Patient Safety and Quality Healthcare journal, May/June 2005) and the worldwide demand for such operations is escalating with the majority of countries now undertaking these procedures on a routine basis. Graham Bowland, Joint Managing Director of Surgical Innovations, commented: 'We are delighted to have been accredited by North Shore and look forward to further opportunities to demonstrate our range of surgical instruments. We believe this is a positive step in the growth of the Group and are confident that this invaluable endorsement from pre-eminent surgeons at a respected hospital group will help us gain accredited supplier status in further hospitals across the USA.' - Ends - For further information: Surgical Innovations Group plc Graham Bowland, Managing Director Tel: +44 (0) 113 230 7597 graham.bowland@surginno.co.uk www.sigroupplc.com Hanson Westhouse LLP Tim Feather Tel: +44 (0) 113 246 2610 tim.feather@hansonwesthouse.com www.hansonwesthouse.com Media enquiries: Abchurch Gareth Mead / Justin Heath Tel: +44 (0) 20 7398 7710 gareth.mead@abchurch-group.com www.abchurch-group.com Notes to Editors: Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets. The Group employs over 50 people and is headquartered in Leeds. The Group's medical division is focused on strong international growth in two specialist areas namely minimally invasive surgery, where products are used in 'keyhole' surgery which is more accurately known as laparoscopic surgery, and products for autologous blood transfusion whereby a patient's own blood is recycled. The Group's industrial division utilises Surgical Innovations' core medical device design expertise and technology in innovative engineering applications. For more information, see www.sigroupplc.com This information is provided by RNS The company news service from the London Stock Exchange